Optimizing Treatment Strategies for HR+/HER2- Breast Cancer: ESR1 Mutations and Emerging Therapies : Episode 12
Opinion
Video
Looking Ahead: Expert Future Perspectives in HR+ Breast Cancer
In their concluding remarks, Virginia Kaklamani, MD, DSc, and Heather McArthur, MD, summarize their key insights and perspectives on the management of HR+ breast cancer.
- What other potential advances are you excited about in the HR+ BC space?
Related Videos
Related Content
